BSX Appeal Denied by U.S. Supreme Court
Wade Roush10/7/08
It appears that Natick, MA-based Boston Scientific (NYSE: BSX) will be forced to pay medical products giant Johnson & Johnson the full $703 million patent-infringement award finalized last week by the U.S. District Court of Delaware, after the U.S. Supreme Court declined yesterday to hear the company’s appeal of the case. Johnson & Johnson claimed that Boston Scientific infringed on a coronary artery stent patent owned by its Cordis division. A $521 million judgment against Minneapolis-based Medtronic will also stand, as Medtronic did not appeal the Delaware court’s judgment.
Wade Roush is Xconomy's chief correspondent and editor of Xconomy San Francisco. You can e-mail him at wroush@xconomy.com or follow him on Twitter at twitter.com/wroush.
